Factors Associated With Poor Sleep Quality In Women With Cancer by Mansano-Schlosser et al.
Original ArticleRev. Latino-Am. Enfermagem
2017;25:e2858
DOI: 10.1590/1518-8345.1478.2858
www.eerp.usp.br/rlae
Factors associated with poor sleep quality in women with cancer1
Thalyta Cristina Mansano-Schlosser2
Maria Filomena Ceolim3
Objectives: to analyze the factors associated with poor sleep quality, its characteristics and 
components in women with breast cancer prior to surgery for removing the tumor and throughout 
the follow-up. Method: longitudinal study in a teaching hospital, with a sample of 102 women. 
The following were used: a questionnaire for sociodemographic and clinical characterization, the 
Pittsburgh Sleep Quality Index; the Beck Depression Inventory; and the Herth Hope Scale. Data 
collection covered from prior to the surgery for removal of the tumor (T0) to T1, on average 3.2 
months; T2, on average 6.1 months; and T3, on average 12.4 months. Descriptive statistics and 
the Generalized Estimating Equations model were used. Results: depression and pain contributed 
to the increase in the score of the Pittsburgh Sleep Quality Index, and hope, to the reduction of 
the score – independently – throughout follow-up. Sleep disturbances were the component with 
the highest score throughout follow-up. Conclusion: the presence of depression and pain, prior 
to the surgery, contributed to the increase in the global score of the Pittsburgh Sleep Quality 
Index, which indicates worse quality of sleep throughout follow-up; greater hope, in its turn, 
influenced the reduction of the score of the Pittsburgh Sleep Quality Index.
Descriptors: Sleep; Breast Neoplasms; Depression; Nursing; Hope; Longitudinal Studies.
1 Paper extracted from Doctoral Dissertation “Qualidade do sono e evolução clínica de mulheres com câncer de mama: estudo longitudinal”, 
presented to Faculdade de Enfermagem, Universidade Estadual de Campinas, Campinas , SP, Brazil. Supported by Coordenação de 
Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil and by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), 
Brazil, process #249118/2013-0.
2 Post-doctoral fellow, Faculdade de Enfermagem, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil. Scholarship holder from 
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.
3 Associate Professor, Faculdade de Enfermagem, Universidade Estadual de Campinas, Campinas, SP, Brazil.
How to cite this article
Mansano-Schlosser TC, Ceolim MF. Factors associated with poor sleep quality in women with cancer. 
Rev. Latino-Am. Enfermagem. 2017;25:e2858. [Access ___ __ ____]; Available in: ____________________.  DOI: 
http://dx.doi.org/10.1590/1518-8345.1478.2858. daymonth year URL
www.eerp.usp.br/rlae
2 Rev. Latino-Am. Enfermagem 2017;25:e2858.
Introduction
Breast cancer is a disease which constitutes a 
serious public health problem, due to its high incidence 
and prevalence, as it is the type of cancer which most 
affects women worldwide. The estimate for Brazil for 
the 2016 – 2017 biennial indicates the occurrence of 
approximately 600,000 new cases of cancer, in which 
the epidemiological profile in women indicates breast 
cancer with 58,000 cases(1).
Among the factors which negatively affect their 
quality of life, patients with breast cancer experience the 
presence of depression, anxiety, fatigue, pain and sleep 
disturbances – it being the case that these can also 
contribute to an increase in mortality(2). The relevance 
of studies geared towards understanding these factors 
is undeniable, due to their complexity and to the impact 
they have on these women’s health and daily life.
It is estimated that poor sleep quality is present in 
85% of women with breast cancer, and that, in these 
women, it is shown to be associated with the presence 
of depression, low self-esteem, and pain(3).
The high prevalence of poor quality sleep is 
concerning, as it is frequently found in association with 
worsening of health – affecting the regulation of the 
immunological and inflammatory functions, in the same 
way that it may cause changes in cognition and memory, 
emotional instability, and increase in appetite(4). The 
management of poor quality sleep is important in these 
women, and should be preceded by the identification of 
the factors associated with it, at different points of the 
diagnosis and treatment.
A recent literature review, in patients who finished 
their treatment for breast cancer, demonstrates that 
they continue to experience some symptoms in the 
long-term: fatigue, depression, sleep disturbances 
and cognitive dysfunction. These symptoms often 
persist after the end of the treatment, resulting in a 
series of negative impacts on the patient’s quality of 
life. This points to the relevance of follow-up surveys 
on these women for the better understanding of the 
interrelationship between these symptoms(5).
Besides symptoms which negatively impact sleep 
quality, there are positive aspects such as hope, which 
can and must be encouraged in patients with cancer, 
constituting a strategy which can help the patient 
to cope with the disease and minimize the impact of 
adverse symptoms(6-7).
This being the case, this study’s objective was: to 
analyze the factors associated with poor sleep quality, 
its characteristics and components in women with breast 
cancer, prior to the surgery for removing the tumor, and 
throughout the follow-up.
Methods
An analytical and longitudinal study, undertaken 
in a Women’s Comprehensive Healthcare Center, with 
major coverage in the state of São Paulo, covering 42 
municipalities and with nearly five million people treated 
each year.
The study had the following inclusion criteria: 
women aged 18 years old or over, with a diagnosis of 
breast cancer, TNM0 at any stage
(8), who were undertaking 
adjuvant chemotherapy and/or radiotherapy throughout 
the treatment, being treated in a hospital specialized in 
attendance to women, and receiving inpatient treatment 
due to mastectomy or quadrantectomy. The TNM system 
is the main system used in the staging of cancer, in 
accordance with Tumor (T), Node (N) and Metastasis 
(M); as an inclusion criteria, the researchers included 
those women in (0, 1, 2 or 3) and M0 as ‘without 
metastasis’(8). The exclusion criteria for the study were: 
Karnofsky Scale below 70 (the individual is able to care 
for herself for the majority of her needs, but these 
require a greater or lesser degree of dependence on 
the help of third parties); inadequate clinical conditions 
(such as mucositis, pain, nausea, dyspnea or vomiting) 
and inadequate emotional conditions (such as crying, 
apathy or aggression) for responding to an interview.
All the women receiving inpatient treatment due 
to surgery for removal of the tumor during the interval 
stipulated for data collection were included in the study, 
as long as they satisfied the selection criteria, totaling 
156 participants at the beginning of the treatment (T0). 
None of the women approached declined to participate. 
These women were monitored over 12.4 months, on 
average, during the clinical treatment in the outpatient 
centers of the above-mentioned hospital. Due to the 
losses to follow-up (failure to appear for interview, deaths 
and incompleteness of data in the medical records), the 
study was undertaken with 102 women who completed 
all four stages of the study (T0, T1, T2 and T3).
The study was undertaken from March 2013 (the 
beginning of the baseline or T0) until December 2014 
(end of data collection) of T3). The last participant was 
included in December 2013. The instruments used were 
the Sociodemographic and Clinical instruments (in T1 
and T3); the Pittsburgh Sleep Quality Index (translated 
and validated for Brazil) (PSQI-BR), the Beck Depression 
Inventory (BDI) and the Herth Hope Scale (HHS), these 
at all points. The collection times are found in Figure 1.
The data collection instruments used were answered in 
the form of interview at the four points of the investigation, 
with the exception of the Sociodemographic and Clinical 
Characterization Questionnaire, which was used at the 
beginning and end of the study. These were, namely:
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- Sociodemographic and Clinical Characterization 
Questionnaire: adopted based on a study undertaken 
in patients with cancer(9) and subjected to content 
validation by specialists. This contains questions for 
sociodemographic and clinical characterization of the 
sample and was answered by the women and confirmed 
in the medical records by the researcher. In the medical 
records there were incomplete areas referent to clinical 
issues of the tumor such as the hormones estrogen and 
progesterone, or data on staging, which lead to loss to 
follow-up.
- The Pittsburgh Sleep Quality Index (PSQI-BR)(10): 
validated in Brazil(11). This allows the subjective 
assessment of sleep quality and problems throughout 
the month prior to the application of the questionnaire. 
It contains 19 questions, grouped in seven components: 
subjective sleep quality, latency, duration, efficiency, 
sleep disturbances, use of sleeping medication and 
daytime dysfunction. The global score varies from 
0 – 21 points, and higher values correspond to worse 
assessment of sleep. When above five, it indicates poor 
sleep quality(11).
- The Beck Depression Inventory (BDI)(12): a self-
assessment measurement of depression, broadly used in 
research and in clinical practice, validated in Brazil(13). The 
original scale consists of 21 items, including symptoms 
and attitudes, whose intensity varies from zero to three. 
The items refer to sadness, pessimism, a feeling of 
failure, lack of satisfaction, feelings of guilt, feelings of 
punishment, self-deprecation, self accusation, suicidal 
ideation, bouts of crying, irritability, social withdrawal, 
indecisiveness, distortion of body image, work inhibition, 
sleep disturbance, fatigue, lack of appetite, weight 
loss, somatic preoccupation and reduction in libido. 
The following cut-off points were observed: below 10 
– without depression, or with minimal depression; from 
10 to 18 – mild to moderate depression; from 19 to 
29 – moderate to serious depression; and 30 to 63 – 
severe depression(12). Next, they were grouped into two 
categories: “without depression” and “with depression” 
(encompassing mild, moderate and severe depression).
- The Herth Hope Scale (HHS)(14), validated for use 
in Brazil(15). This is made up of 12 statements with 
responses on a Likert-type scale (values of 1 to 4), 
with the following possibilities for response: disagree 
completely, disagree, agree, and agree completely. The 
total score varies from 12 to 48 points; the higher the 
score, the higher the level of hope(15).
The treatment of the data was undertaken with the 
support of a statistician, and consisted of the descriptive 
analysis and construction of the Generalized Estimating 
Equations model (GEE)(16), for the identification of factors 
present in T0 which influenced sleep quality throughout 
the follow-up period. A level of significance of 5% was 
considered. The analysis of reliability of the PSQI-BR 
was undertaken using the Cronbach alpha coefficient.
The ethical considerations were respected, in 
accordance with Resolution 466/2012, of the National 
Health Council, and the study was approved by the 
Research Ethics Committee of the institution to which this 
study’s authors are affiliated, under Opinion N. 44169, 
CAAE 00762112.0.0000.5404 and its amendment was 
approved on 23rd June 2015, under Opinion N. 1.106.951.
Results
The 102 participants presented a mean age of 56.2 
(SD 12.5) years old and stated an average of 5.3 (SD 
4.0) years of study. Other sociodemographic and clinical 
data are provided in Table 1. The staging of the cancer 
was grouped in I/II as it is considered to be initial and 
constituted the majority of cases in this study.
Table 1 - Sociodemographic and clinical characteristics 
of the women with breast cancer who participated in the 
study (n=102). Campinas, SP, Brazil, 2013-2014
Sociodemographic and clinical characteristics N %
Marital status 
Has partner 56 54.9
Work situation 
Retired 47 46.1
Employed 23 22.6
Unemployed 32 31.4
Night prior to the
mastectomy
Mean 3.2
months (SD 0.7)
after T0
Mean 6.1
months (SD 0.9)
after T0
Mean 12.4
months (SD 1.0)
after T0
Sociodemographic
and Clinical
Sociodemographic
and Clinical
PSQI-BR*
BDI†
HHS‡ PSQI-BR*
BDI†
HHS‡
PSQI-BR*
BDI†
HHS‡
PSQI-BR*
BDI†
HHS‡
T0 T1 T2 T3
PSQI-BR*: Pittsburgh Sleep Quality Index (Brazil); BDI†: the Beck Depression Inventory; HHS‡: Herth Hope Scale
Figure 1 - Description of the data collection times and instruments used in the women with breast cancer (n=102) 
Campinas, São Paulo, Brazil
(continue...)
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Sociodemographic and clinical characteristics N %
With whom patient lives 
Family members 90 88.2
Alone 7 06.9
Others 5 04.9
Family income 
Up to 5 minimum salaries* 93 91.2
6 to 10 minimum salaries 9 08.8
Report of any other chronic illness 
Yes 37 36.3
Symptoms related to the menopause 
Yes 36 35.3
Report of pain 
Yes 40 39.2
Staging (according to the TNM)†
I/II 83 81.4
III 19 18.6
Neoadjuvant chemotherapy 
Yes 26 25.2
Surgery undertaken 
Mastectomy 57 55.9
Quadrantectomy 44 43.1
No information 01 01.0
*Minimum salaries in Brazilian reais R$ 724.00 Brazil, 2014; †TNM: Tumor 
(T), Node (N) and Metastasis (M).
Regarding the classification of depression in T0, 
52.0% of the participants were in the category ‘without 
depression or minimal depression’, 18.6% had mild 
to moderate depression, and 29.4% had moderate 
or severe depression. The score for depression was 
identified as 11.2 (SD 9.2) on average. Hope, according 
to the HHS, obtained at T0 a mean score of 34.5 points 
(SD 6.3). The results of the descriptive statistics for the 
sleep characteristics, of the total score and all of the 
components of the PSQI-BR during follow-up are found 
in Table 2.
Poor quality sleep, estimated by the score of the 
PSQI-BR, was observed in 57.8% of the women in T0, 
56.9% in T1, 55.9% in T2 and 61.8% in T3.
Table 3 shows the factors which influenced the final 
score of the PSQI-BR, identified with the Generalized 
Estimating Equations model.
Table 2 - Characteristics of sleep and components of the Pittsburgh Sleep Quality Index in women with breast cancer (n=102). Campinas, SP, Brazil, 
2013/2014
T0 T1 T2 T3
M* SD† Med‡ M* SD† Med‡ M* SD† Med‡ M* SD† Med‡
Sleep characteristics 
Duration (hours) 6.5 01.9 7.0 6.4 2.0 7.0 6.5 1.9 7.0 7.0 1.5 7.5
Efficiency (%) 95.8 27.6 94.0 86.3 23.5 86.0 87.5 24.7 89.0 88.4 19.9 89.0
Components of the PSQI§-BR
Sleep quality 1.2 1.3 1.0 1.2 1.3 1.0 1.2 1.2 1.0 1.5 1.2 1.0
Latency 1.4 0.9 2.0 1.3 1.5 1.0 1.3 1.0 1.0 1.2 0.9 1.0
Duration 1.0 1.2 1.0 1.2 1.2 1.0 1.1 1.1 1.0 0.7 0.9 0.5
Efficiency 0.8 1.1 0.0 1.1 1.2 0.0 1.0 1.2 0.0 0.8 1.1 0.0
Disturbances 1.4 0.6 1.0 1.5 0.6 1.0 1.5 0.6 1.5 1.6 0.6 2.0
Use of sleeping medication 0.8 1.3 0.0 0.5 1.0 0.0 0.7 1.2 0.0 0.9 1.2 0.0
Daytime dysfunction 0.5 0.8 0.0 0.4 0.7 0.0 0.7 0.7 1.0 0.9 0.9 1.0
Total score of the PSQI-BR 7.1 4.4 7.0 7.3 4.7 6.5 7.4 4.8 6.5 7.3 4.3 7.0
*M: mean
†SD: standard deviation
MED: median
§PSQI- Pittsburgh Sleep Quality Index – Brazil (BR)
Table 1 - (continuation)
Table 3 - Factors which influenced sleep quality throughout the follow-up according to the Generalized Estimating 
Equations model. Campinas, SP, Brazil, 2013-2014.
Factors Coefficient Confidence Interval 95% p-value
Age (years) 0.03 -0.04 -0.09 0.4108
Marital status (ref*: married) 0.54 -0.68 1.76 0.3892
Years of study (years) 0.09 -0.09 0.26 0.3235
Symptoms of the menopause (ref: no) 0.28 -0.99 1.55 0.6697
Staging of the tumor (ref: I or II) 1.25 -0.16 2.66 0.0822
Neoadjuvant chemotherapy (ref: no) 0.02 -1.47 1.51 0.9775
Dimension of the tumor (centimeters) -0.13 -0.44 0.18 0.4009
Depression (ref: absent or minimal) 2.23 1.42 3.04 0.0001
Pain (ref: no) 1.31 0.01 2.62 0.0481
Score of the HHS† (score) -0.08 -0.14 -0.02 0.0105
*Ref: indicates the reference category for the factor
†Herth Hope Scale
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The presence of depression and complaints of 
pain presented a significant effect on quality of sleep 
throughout the follow-up, contributing to the increase in 
the score of the PSQI-BR. In the same way, lower scores 
of the HHS were related to the increase in the score of 
the PSQI-BR.
The analysis of the reliability of the PSQI-BR 
ascertained satisfactory results for the Cronbach alpha 
coefficient at the four points: T0 – 0.721, T1 – 0.782, 
T2 – 0.795 and T3 – 0.771.
Discussion
Depression, pain and hope influenced sleep quality 
throughout the follow-up, with depression being the 
most significant factor in this study. In the literature, few 
investigations focus on the longitudinal monitoring(17), 
considering that most researchers analyze cross sections 
in the different stages, and not the joint influence over 
the entire period(9,18). Furthermore, data analyzed based 
on a longitudinal study after two years’ treatment 
evidenced that the presence of some symptoms prior 
to the surgery had a predictive effect in the long-term 
on the quality of life of women with breast cancer, and 
the five symptoms present were: sleep disturbances, 
cognitive issues, physical tiredness, depression and 
anxiety. These authors concluded that it is necessary to 
assess symptoms in the pre-treatment period, in order 
to identify high-risk groups(19).
In this study, the presence of depression and 
complaints of pain presented a significant effect on 
sleep quality over time, contributing to the increase 
in the score of the PSQI-BR. In one longitudinal study 
undertaken with 3343 women with breast cancer at an 
initial stage, evaluated 3 to 4 months after the surgery 
for resection of the tumor, the authors ascertained 
that depression was the strongest predictive factor for 
sleep alterations, a data which corroborates the present 
study(20). Other researchers assessed 390 women with 
breast cancer prior to mastectomy and up to six months 
after, observing that more serious depressive symptoms 
were predictors of greater sleep alterations prior to the 
surgery, although this influence declined by the end of 
the follow-up(17).
Coping with diseases which have poor prognoses, 
such as cancer, often entails the patient’s psychological 
imbalance, and sometimes, in the daily routine of the 
services, there is no time for listening to the patient; 
also, the patient may feel discouraged from perceiving 
or talking about her feelings, distress or fear of death. 
There are specific instruments, as in the present study, 
which can be administered by health professionals for 
identifying such complaints and possible illnesses, such 
as depression(13).
It should be highlighted that factors such as 
depression, for example, if not treated, may be present 
for years after the clinical treatment of the cancer(2).
Compromising of sleep quality is considered to be 
a factor present in depression, so much so that one 
question regarding this forms part of the instrument 
for tracking depression used in this study. Authors have 
argued that the attempt to establish a unidirectional 
causal relationship might represent a simplification of 
an association which is in fact fairly complex, such that 
depressive symptoms can lead to poor sleep quality, 
and changes in sleep may contribute to the presence of 
depression in these women(20).
Besides depression, pain was also a significant 
influence on poor quality sleep in this study. It is a 
frequent symptom in these patients, affecting 39.2% 
of the women in this study. High levels of depression, 
anxiety and sleep disturbances were present in women 
with breast cancer and who reported pain, in comparison 
with the group of women who did not have pain(21).
Sociodemographic variables such as age and years 
of study were not significant in this study, in contrast 
with other authors, who showed that advanced age 
and fewer than seven years in full-time education were 
independent predictors of poor quality sleep(20). In the 
present study, the majority of the women (75%) had 
been to school for fewer than eight years – and 50%, for 
fewer than four years, indicating greater homogeneity 
in this aspect, a fact which may explain the absence of 
results for this variable.
Poor quality of sleep was identified in 57.8% of the 
women at the beginning of the study, data which is similar 
to that of another longitudinal study with women with 
breast cancer, in which 57.9% of the women presented 
poor quality sleep(20). A previous longitudinal study with 
80 patients with breast cancer showed that poor quality 
sleep (PSQI ≥ 5) predominated at all points of the 
treatment (48.5-65.8%)(22). In the present study, at the 
end of the follow-up, poor quality sleep persisted with 
an increase in the percentage of the women (61.8%) 
similar to that in a study with 166 women with breast 
cancer in which the results in the PSQI suggest that the 
women reported poor quality sleep prior to beginning 
treatment and mentioned even worse quality sleep after 
the end of the same(23).
Regarding the components of the PSQI-BR, the 
component ‘Sleep disturbances’ obtained the highest 
score at all points, similar to the results found in 
another study monitoring women with breast cancer(24). 
However, for these authors, the component ‘Use of 
sleeping medication’ obtained the lowest score, taking 
www.eerp.usp.br/rlae
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into account that in the present study it was ‘Daytime 
dysfunction’ that obtained the lowest score(24). It should 
be emphasized that various aspects which participate in 
the component ‘Sleep disturbances’ are related to poor 
quality sleep in people with cancer, with emphasis placed 
on waking up early and the fragmentation of sleep, both 
for various reasons, such as the need to go to the toilet, 
pain, and worry(21).
It stands out that high scores in the component 
of ‘Sleep Disturbances’ did not entail high scores in 
‘Daytime Dysfunction’, suggesting that these women, 
although not sleeping well at night for the possible 
reasons mentioned above, did not complain significantly 
about the difficulty of remaining awake during their 
routine activities.
This study was guided by the need to identify factors 
which could be associated with poor sleep quality, as 
well as those which could contribute to its improvement. 
In a positive way – in this study – hope was shown to 
be effective for reducing the score of the PSQI-BR. It 
could, therefore, be used as a strategy by the health 
professionals for encouragement in coping better with 
the disease and the patients’ day-to-day(7).
Hope has been indicated as one of the resources 
for coping with breast cancer to be used in the practice 
of the health professionals, which could have positive 
consequences for sleep quality – although modest, as 
this study’s findings suggest.
Based on this study’s results, emphasis is placed 
on the need for longitudinal assessment of the quality 
and changes in sleep before, during and even after the 
treatment of the cancer, bearing in mind the persistence 
of poor quality sleep. In the same way, the relevance 
of planning and implementing interventions focusing 
on the modifiable factors which influence sleep quality, 
such as depression, pain and encouragement to hope, 
is surmised.
It is emphasized that the treatment of depression is 
known and that the identification of this threat to health 
is therefore necessary for it to be monitored and treated 
effectively. However, considering that hope constitutes a 
little-known factor, the need is evidenced for the health 
professionals to extend their knowledge in relation to it, 
for them to make use of the assessment instrument and 
seek a theoretical basis to make it possible to implant 
strategies in clinical practice. In the international 
literature, interventions encouraging hope are found in 
few studies - among which there is one investigation 
among carers of people with advanced cancer(25), with 
results that the authors evaluated as satisfactory.
Further studies are necessary for assessing specific 
characteristics of the relationships between the factors 
identified in this study, and of the mechanisms for the 
management of the same which contribute to maintaining 
sleep quality or letting it worsen; and, furthermore, to 
ascertain whether there is a causal relationship rather 
than just of association between these variables, and 
the extent to which the treatment of depression and 
pain – and encouragement to hope – could contribute 
to improving assessment of sleep quality, in different 
stages of the treatment of the cancer, these necessarily 
being evaluated and treated by the health professionals.
As factors limiting the study, emphasis is placed 
on losses to follow up due to the women not attending, 
and to losses of data due to the lack of completeness of 
the medical records, reducing the sample size and the 
possibility of generalization of the results.
This study contributes to the advancement of 
the scientific knowledge of Brazilian and international 
Nursing, regarding the need for longitudinal assessment 
of sleep quality and the possibility of this in nurses’ 
clinical practice or in the international journals which 
focus on modifiable influencing factors of sleep quality, 
such as depression, pain and encouragement to hope. 
Both the study and the knowledge of hope – as yet, 
studied but little in Brazil – might contribute as an 
innovation in Brazilian nursing science.
Conclusion
The presence of depression and of pain prior to the 
surgery for the removal of the breast cancer contributed 
to the increase in the global score of the PSQI-BR, which 
indicates worse sleep quality, throughout the follow-up 
of the women in this study. The highest scores of the 
HHS, that is to say, the greatest hope, in their turn, 
influenced the reduction of the score of the PSQI-BR.
The persistence of poor quality sleep throughout 
the follow-up emphasizes the importance of assessing 
this parameter in patients with cancer, as well as of 
the relevance of the planning of interventions geared 
towards its improvement. This planning is only possible 
in conjunction with the identification of the factors which 
influence sleep quality.
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